- Home
- WF vs BRKR Comparison
WF vs BRKR Comparison
Compare WF & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WF | BRKR |
|---|---|---|
| Founded | 1899 | 1960 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.6B | 7.3B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | WF | BRKR |
|---|---|---|
| Price | $59.19 | $53.28 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $49.69 |
| AVG Volume (30 Days) | 54.0K | ★ 2.0M |
| Earning Date | 10-29-2025 | 02-12-2026 |
| Dividend Yield | ★ 3.62% | 0.38% |
| EPS Growth | ★ 20.51 | N/A |
| EPS | ★ 2.97 | N/A |
| Revenue | ★ $8,054,512,650.00 | $3,438,900,000.00 |
| Revenue This Year | N/A | $3.55 |
| Revenue Next Year | $4.37 | $1.49 |
| P/E Ratio | $6.42 | ★ N/A |
| Revenue Growth | ★ 23.56 | 6.10 |
| 52 Week Low | $29.44 | $28.53 |
| 52 Week High | $60.48 | $64.64 |
Technical Indicators
Market Signals| Indicator | WF | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 61.11 | 71.67 |
| Support Level | $58.35 | $46.85 |
| Resistance Level | $60.48 | $48.73 |
| Average True Range (ATR) | 1.02 | 1.61 |
| MACD | 0.05 | 0.33 |
| Stochastic Oscillator | 74.78 | 91.88 |
Price Performance
Historical ComparisonAbout WF Woori Financial Group Inc. (each representing three (3) shares of)
Woori Financial Group Inc is a banking and financial services holding company that offers a wide range of services, including corporate banking, consumer banking, credit card operations, investment banking, capital markets activities, international banking, asset management, and other businesses. The operating segments of the company include Banking, Credit card, Capital, Investment banking, and others.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.